ArticleWorld journal of urology2024

Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis.

Andreas Karlsson Rosenblad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.